These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 22522381)

  • 1. Accurate mean comparisons for paired samples with missing data: an application to a smoking-cessation trial.
    Xu J; Harrar SW
    Biom J; 2012 Mar; 54(2):281-95. PubMed ID: 22522381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Missing data assumptions and methods in a smoking cessation study.
    Barnes SA; Larsen MD; Schroeder D; Hanson A; Decker PA
    Addiction; 2010 Mar; 105(3):431-7. PubMed ID: 20402986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why assigning ongoing tobacco use is not necessarily a conservative approach to handling missing tobacco cessation outcomes.
    Nelson DB; Partin MR; Fu SS; Joseph AM; An LC
    Nicotine Tob Res; 2009 Jan; 11(1):77-83. PubMed ID: 19246444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of individual long-term outcomes in smoking cessation trials using frailty models.
    Li Y; Wileyto EP; Heitjan DF
    Biometrics; 2011 Dec; 67(4):1321-9. PubMed ID: 21401566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing missing data assumptions in longitudinal studies: an example using a smoking cessation trial.
    Yang X; Shoptaw S
    Drug Alcohol Depend; 2005 Mar; 77(3):213-25. PubMed ID: 15734221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonparametric empirical Bayes method for comparison of treatment effects with application to stress urinary incontinence data.
    Liu C; Shen W; Xie J
    Pharm Stat; 2008; 7(1):42-52. PubMed ID: 17311241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of nonresponse patterns in the analysis of smoking cessation trials.
    Twardella D; Brenner H
    Nicotine Tob Res; 2008 May; 10(5):891-6. PubMed ID: 18569764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Smoking cessation and pregnancy].
    Møller AM; Tønnesen H
    Ugeskr Laeger; 1999 Sep; 161(36):4985-6. PubMed ID: 10489788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. If you try to stop smoking, should we pay for it? The cost-utility of reimbursing smoking cessation support in the Netherlands.
    Vemer P; Rutten-van Mölken MP; Kaper J; Hoogenveen RT; van Schayck CP; Feenstra TL
    Addiction; 2010 Jun; 105(6):1088-97. PubMed ID: 20659063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of group sequential methods for binary longitudinal data.
    Spiessens B; Lesaffre E; Verbeke G
    Stat Med; 2003 Feb; 22(4):501-15. PubMed ID: 12590410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Might stopping smoking reduce injury death risks? A meta-analysis of randomized, controlled trials.
    Leistikow BN; Shipley MJ
    Prev Med; 1999 Mar; 28(3):255-9. PubMed ID: 10072743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Test homogeneity of odds ratio in a randomized clinical trial with noncompliance.
    Lui KJ; Chang KC
    J Biopharm Stat; 2009 Sep; 19(5):916-32. PubMed ID: 20183452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The paucity of effects in community trials: is secular trend the culprit?
    Bauman KE; Suchindran CM; Murray DM
    Prev Med; 1999 Apr; 28(4):426-9. PubMed ID: 10090872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Missing data handling methods in medical device clinical trials.
    Yan X; Lee S; Li N
    J Biopharm Stat; 2009 Nov; 19(6):1085-98. PubMed ID: 20183466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bias correction in testing treatment efficacy under informative dropout in clinical trials.
    Kong F; Chen YF; Jin K
    J Biopharm Stat; 2009 Nov; 19(6):980-1000. PubMed ID: 20183460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Smoking cessation for hospital staff. A controlled intervention study].
    Michalsen A; Richarz B; Reichardt H; Spahn G; Konietzko N; Dobos GJ
    Dtsch Med Wochenschr; 2002 Aug; 127(34-35):1742-7. PubMed ID: 12192632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of average treatment effect with incompletely observed longitudinal data: application to a smoking cessation study.
    Chen HY; Gao S
    Stat Med; 2009 Aug; 28(19):2451-72. PubMed ID: 19462416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Issues with statistical risks for testing methods in noninferiority trial without a placebo ARM.
    Hung HM; Wang SJ; O'Neill R
    J Biopharm Stat; 2007; 17(2):201-13. PubMed ID: 17365218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers.
    Ferguson SG; Gitchell JG; Shiffman S; Sembower MA
    Clin Ther; 2009 Sep; 31(9):1957-65. PubMed ID: 19843485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous test for superiority and noninferiority hypotheses in active-controlled clinical trials.
    Tsong Y; Zhang J
    J Biopharm Stat; 2007; 17(2):247-57. PubMed ID: 17365221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.